The Hepatitis A market is projected to experience robust growth, fueled by the launch of innovative therapies, rising disease prevalence, and heightened healthcare investments across key regions. Industry leaders, including Boryung Pharmaceutical, Cadila Healthcare, Indian Immunologicals, Biological E Limited, Sinovac Biotech Co., Ltd, Sanofi, GlaxoSmithKline, Crucell Holland BV, and Merck,...